ArticleHepatology (Baltimore, Md.)2010
The epithelial-to-mesenchymal transition in liver fibrosis: here today, gone tomorrow?
Article in Hepatology (Baltimore, Md.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed.
- Modulation of phosphatase of regenerating liver-1 within placental mesenchymal stem cells instigates the transition between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition subsequent to hepatic fibrosis.Clinical and molecular hepatology · 2025Article
- Lack of basic rationale in epithelial-mesenchymal transition and its related concepts.Cell & bioscience · 2024Review
- Plasticity, heterogeneity, and multifunctionality of hepatic stellate cells in liver pathophysiology.Hepatology communications · 2024Review
- Article
- Expression of cytokeratin-7 and cytokeratin-19 on newborn mice induced rhesus rotavirus as biliary atresia model.The Pan African medical journal · 2022Article
- Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges.World journal of gastroenterology · 2021Review
- Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial-Mesenchymal Transition (EMT).Cell biochemistry and biophysics · 2021Article
- Review
- Increased Expression of Adherens Junction Components in Mouse Liver following Bile Duct Ligation.Biomolecules · 2019Article
- miR-219-3p regulates the occurrence of hepatic fibrosis by targeting Smad2.Experimental and therapeutic medicine · 2019Article
- Stem Cell Differentiation is Regulated by Extracellular Matrix Mechanics.Physiology (Bethesda, Md.) · 2018Review
- SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.EMBO molecular medicine · 2017Article
- Fate tracing of hepatocytes in mouse liver.Scientific reports · 2017Article
- Can a fibrotic liver afford epithelial-mesenchymal transition?World journal of gastroenterology · 2017Review
- Fibronectin fibrils regulate TGF-β1-induced Epithelial-Mesenchymal Transition.Matrix biology : journal of the International Society for Matrix Biology · 2017Article
- Adverse outcome pathway development from protein alkylation to liver fibrosis.Archives of toxicology · 2017Review
- Common pathway signature in lung and liver fibrosis.Cell cycle (Georgetown, Tex.) · 2016Article
- Article
- Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial Phenotype.Stem cells international · 2016Review
- Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition.World journal of hepatology · 2014Review
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.